Recommended Adult Immunization Schedule: United States, October 2007September 2008*

  title={Recommended Adult Immunization Schedule: United States, October 2007September 2008*},
  author={Raymond J. Gibbons and Stephan D. Fihn},
  journal={Annals of Internal Medicine},
The Advisory Committee on Immunization Practices (ACIP) annually reviews the recommended Adult Immunization Schedule to ensure that the schedule reflects current recommendations for the licensed vaccines. In June 2007, ACIP approved the Adult Immunization Schedule for October 2007September 2008. This schedule has also been approved by the American Academy of Family Physicians, American College of Obstetricians and Gynecologists, and American College of Physicians. Changes in the Schedule for… 

Live, Attenuated Varicella Zoster Vaccination of an Immunocompromised Patient

The consequences of Zostavax® administration to adult cancer patients immunocompromised by systemic chemotherapy are described, believed to be the first to describe the consequences of this vaccine to such a host.

Influenza immunization for college students: An important intervention that can improve class attendance and help keep up with homework.

The pharmacist’s unique relationship with parents and students offers the opportunity to make a difference in this often overlooked patient population and raise influenza vaccination awareness.

Preventive Vaccinations of Respiratory Infections during Lung Transplantation

To consider the current state of the use of vaccine prophylaxis in the integrated management of patients before and after lung transplantation, the prevention of respiratory infections in adult candidates for organ transplantation and recipients is recommended.

[Regional differences in access to coronary bypass surgery in Brazil, 2002-2010].

Comparison with international data shows that Brazil has lower rates than those observed in OECD countries, and the definition of regional health care networks for cardiac surgery is an important strategy to ensure the quality of care, optimization of operating costs and reduction of inequalities in access to healthcare between Brazilian regions.

La chirurgie coronaire sous circulation extra-corporelle chez le patient diabétique

La chirurgie coronaire chez le diabétique offre d'excellents résultats à court et à moyen terme au détriment d'une faible morbi-mortalité ce qui en fait le traitement de choix.

Percutaneous coronary intervention versus coronary artery bypass graft in chronic kidney disease: Optimal treatment options

A review of the current literature supports the superiority of coronary artery bypass grafting which reduces repeat revascularizations, improves angina symptoms, and increases long‐term survival.



1999 National Hospital Discharge Survey

This report presents national estimates of the use of non-Federal short-stay hospitals in the United States during 1999, including the number and rate of discharges and average lengths of stay by the age and sex of patients and by geographic region of hospital.

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

The American Heart Association works with the Centers for Disease Control and Prevention’s National Center for Health Statistics (CDC/NCHS), the National Heart, Lung, and Blood Institute (NHLBI, the National Institute of Neurological Disorders and Stroke (NINDS), and other government agencies to derive the annual statistics in this update.

Developing a center for comparative effectiveness information.

  • G. Wilensky
  • Medicine, Political Science
    Health affairs
  • 2006
Careful consideration needs to be given regarding the appropriate structure, placement, financing, and function of an agency devoted to comparative effectiveness if it is to achieve its objective: a mechanism to support better decision making in health care.

Optimal medical therapy with or without PCI for stable coronary disease.

As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy.

Twelve-year follow-up of survival in the randomized European Coronary Surgery Study.

The improvement in the survival rate among patients with stable angina who were treated surgically appears to have been attenuated after five years, and the gradually diminishing difference between the two survival curves still favored surgical treatment after 12 years.

A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction.

It is concluded that patients with triple-vessel disease and ejection fractions above 0.34 but lower than 0.50 appear to have improved seven-year survival with elective bypass surgery.